With type 2 diabetes on the rise, more people than ever are being prescribed medication to help control the disease. Actos (pioglitazone) took over the top spot as the most commonly-prescribed drug to treat type 2 diabetes when the FDA restricted the prescribing of Avandia, an antidiabetic drug shown to be associated with an increased risk of heart attack, stroke, and death. Research in Europe, Canada, and the United States has shown that Actos may pose an even greater variety of health risks than its predecessor.
This information has been provided as an educational resource only, contact an experienced Actos attorney where required.